Results 141 to 150 of about 462,808 (314)

Nationwide Temporal Trends in Adverse Pregnancy Outcomes and Treatments in Systemic Lupus Erythematosus Pregnancy Over Two Decades in Sweden

open access: yesArthritis &Rheumatology, EarlyView.
Objective This nationwide descriptive study examined temporal trends in adverse pregnancy outcomes (APOs) and treatments in systemic lupus erythematosus (SLE) pregnancies in Sweden over 2003 to 2022. Methods Using nationwide Swedish registers, we identified 1,417 pregnancies of women with prevalent SLE and delivery dates in 2003 to 2022 and matched ...
Ngoc V. Nguyen   +6 more
wiley   +1 more source

Clinical Features, Treatment Effectiveness and Long-Term Outcomes in Children with Moderate-to-Severe Generalized Pustular Psoriasis: A Retrospective Cohort Study

open access: yesJournal of Inflammation Research
Zhiqiang Cao,1,* Bin Peng,1,* Zonghao Li,2 Ruiqi Li,1 Ruitao Fan,1 Baibing Mi,2 Bingjie Li,1 Xiangjin Song,1 Jing Shi,1 Songmei Geng1 1Department of Dermatology, Northwest Hospital, The Second Hospital Affiliated of Xi’an Jiaotong ...
Cao Z   +9 more
doaj  

DERMATOLOGY [PDF]

open access: yesThe American Journal of the Medical Sciences, 1887
openaire   +3 more sources

Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database

open access: yesArthritis &Rheumatology, EarlyView.
Objective The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasingly available immunosuppressive therapies (ISTs) and antifibrotic treatments. However, their real‐world use remains unclear.
Corrado Campochiaro   +17 more
wiley   +1 more source

Analysis of the Efficacy and Safety of Secukinumab Combined with Surgical Treatment for Hidradenitis Suppurativa: A Real-World Retrospective Study in China

open access: yesJournal of Inflammation Research
Xiaojie Liu,1,* Chuanjian Yuan,2,* Yuan Kang,3,* Jun Zhang,1 Yibo Li,1 Ruiqi Wang,1 Chen Ding,1 Junling Zhang,1,* Weibin Xing1,* 1Department of Dermatology, Affiliated Hospital of Tianjin Academy of Traditional ...
Liu X   +8 more
doaj  

TWEAK/Fn14 Signaling Drives Oxidative Cardiac Injury in Systemic Lupus Erythematosus: Evidence From Patient Biomarker Studies, Lupus Mouse Models, and Cardiomyocyte Assays

open access: yesArthritis &Rheumatology, EarlyView.
Objective Cardiac involvement is a major cause of morbidity in systemic lupus erythematosus (SLE). Tumor necrosis factor–like weak inducer of apoptosis (TWEAK) is elevated in SLE, but its contribution to lupus‐associated cardiac injury is unclear. We investigated the role of TWEAK/fibroblast growth factor–inducible 14 (Fn14) signaling in SLE‐related ...
Yale Liu   +12 more
wiley   +1 more source

The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasis

open access: yesPsoriasis: Targets and Therapy
Yanhua Liang,1 Baoqing Deng,2 Epipode Ntawuyamara,3 Hervé Bachelez,4 Fuxi Wang,5 Hao Zhang,6 Zhenying Zhang,7 Zhengfeng Li,7 Lin Dang,8 Yajie Wang,1 Xianbiao Zou,9 Li Wang,10 Dejian Duan,11 Hongxiang Chen,12 Wenjun Zheng,13 Hui Huang,14 Min Zhang,15 ...
Liang Y   +22 more
doaj  

Congenital Hypotrichosis in a female Rottweiler [PDF]

open access: yes, 1993
Ihrke, P. J.   +2 more
core   +1 more source

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial

open access: yesArthritis &Rheumatology, EarlyView.
Objective Overweight or obesity is prevalent in 72% to 82% of individuals with psoriatic arthritis (PsA). We assessed the efficacy and safety of ixekizumab (IXE) concomitantly administered with tirzepatide (TZP) compared with IXE alone in adult participants with active PsA and overweight with at least one weight‐related comorbidity or obesity.
Joseph F. Merola   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy